Cardioprotection by ischemic postconditioning during surgical procedures

Expert Review of Cardiovascular Therapy

Volumn 6, Issue 7, 2008, Pages 999-1006

  Sadat, Umar ^a   Walsh, Stewart R ^a   Varty, Kevin ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Cardiac arrhythmias; Cardioprotection; Ischemia; Ischemic reperfusion injury; Postconditioning; Preconditioning

Indexed keywords

CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCOGEN SYNTHASE KINASE 3BETA; GUANYLATE CYCLASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; REACTIVE OXYGEN METABOLITE; S6 KINASE;

ACUTE HEART INFARCTION; AORTA ANEURYSM; AORTA SURGERY; CARDIOVASCULAR SURGERY; ENZYME PHOSPHORYLATION; FALLOT TETRALOGY; HEART ARRHYTHMIA; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HUMAN; MORBIDITY; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTEIN EXPRESSION; REVIEW; SURGICAL MORTALITY; SYSTEMATIC REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; ANIMAL; CLINICAL TRIAL; HEART SURGERY; METHODOLOGY; POSTOPERATIVE COMPLICATION;

ANIMALS; ARRHYTHMIAS, CARDIAC; CARDIAC SURGICAL PROCEDURES; CLINICAL TRIALS AS TOPIC; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS;

EID: 52049121666     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.6.7.999     Document Type: Review

References (69)

1. Godet G, Dumerat M, Baillard C et al. Cardiac troponin I is reliable with immediate but not medium-term cardiac complications after abdominal aortic repair, Acta Anaesthesiol. Scand. 44, 592-597 (2000).
2. Kim LJ, Martinez EA, Faraday N et al. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation 106, 2366-2371 (2002).
3. Andrews N, Jenkins J, Andrews G, Walker P. Using postoperative cardiac Troponin-I (cTi) levels to detect myocardial ischaemia in patients undergoing vascular surgery. Cardiovasc. Surg. 9, 254-265 (2001).
4. Kertai MD, Boersma E, Klein J, Van Urk H, Bax JJ, Poldermans D. Long-term prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery. Eur. J. Vasc. Endovasc. Surg. 28, 59-66 (2004).
5. Landesberg G, Mosseri M, Shatz V et al. Cardiac troponin after major vascular surgery: the role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization. J. Am. Coll. Cardiol. 44, 569-575 (2004).
6. Haggart PC, Adam DJ, Ludman PF, Bradbury AW. Comparison of cardiac troponin I and creatine kinase ratios in the detection of myocardial injury after aortic surgery. Br. J. Surg. 88, 1196-1200 (2001).
7. Barbagallo M, Casati A, Spadini E et al. Early increases in cardiac troponin levels after major vascular surgery is associated with an increased frequency of delayed cardiac complications. J. Clin. Anesth. 18, 280-285 (2006).
8. Maroko PR, Kjekshus JK, Sobel BE et al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 43, 67-82 (1971).
9. DeWood MA, Spores J, Notske R. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. Engl. J. Med. 303, 897-902 (1980).
10. Buckberg GD. Studies of controlled reperfusion after ischemia: I. When is cardiac muscle damaged irreversibly?. J. Thorac. Cardiovasc. Surg. 92, 483-487 (1986).
11. Buckberg GD. Strategies and logic of cardioplegic defivery to prevent, avoid, and reverse ischemic and reperfusion damage. J. Thorac. Cardiovasc. Surg. 93, 127-139 (1987).
12. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J. Clin. Invest. 76, 1713-1719 (1985).
13. Gumina RJ, Gross GJ. If ischemic preconditioning is the gold standard, has a platinum standard of cardioprotection arrived? comparison with NHE inhibition. J. Thrombosis Thrombolysis 8, 39-44 (1999).
14. Przyklenk K, Darling CE, Dickson EW, Whittaker P. Cardioprotection 'outside the box' - the evolving paradigm of remote preconditioning. Basic Res. Gardiol. 98, 149-157 (2003).
15. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'Preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87, 893-899 (1993).
16. Cheung MM, Kharbanda RK, Konstantinov IE et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J. Am. Coll. Cardiol. 47, 2277-2282 (2006).
17. Ali ZA, Callaghan CJ, Lim E et al. Remote ischemic preconditioning reduces myocardial and renal injury afier elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 116(11 Suppl.), 198-105 (2007).
18. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc. Med. 15(2), 69-75 (2005).
19. Sivaraman V, Mudalagiri NR, Di Salvo C et al. Postconditioning protects human atrial muscle through the activation of the RISK pathway. Basic Res. Cardiol. 102(5), 453-459 (2007).
20. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of "modified reperfusion" protects the myocardium. by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 95(3), 230-232 (2004).
21. Darling CE, Jiang R, Maynard M, Whittaker P, Vinten-Johansen J, Przyklenk K. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am. J. Physiol. Heart Circ. Physiol. 289(4), 1618-1626 (2005).
22. Bopassa JC, Ferrera R, Gateau-Roesch O, Couture-Lepetit E, Ovize M. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc. Res. 69(1), 178-185 (2005).
23. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 111(2), 194-197 (2005).
24. Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc. Med. 15(2), 69-75 (2005).
25. Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc. Res. 75(3), 530-535 (2007).
26. Zatta AJ, Kin H, Lee G et al. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc. Res. 70(2), 315-324 (2006).
27. Kin H, Zatta AJ, Lofye MT et al. Post conditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc. Res. 67(1), 124-133 (2005).
28. Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc. Res. 70(2), 308-314 (2006).
29. Solenkova NV, Solodushko V, Cohen MV, Downey JM. Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am. J. Physiol. Heart Circ. Physiol. 290, 441-449 (2006).
30. Yang Z, Xu Y, Lankford AM, Linden J, Vinten-Johansen J, French BA. The cardioprotective effects of postconditioning against acute myocardial infarction are mediated by adenosine A2A receptor activation. Circulation 114(18), 272 (2006).
31. Penna C, Mancardi D, Rastaldo R, Losano G, Pagliaro P. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc. Res. 75, 168-177 (2007).
32. Penna C, Mancardi D, Tullio F, Pagliaro P. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Basic Res. Cardiol. (2008) [Epub ahead of print].
33. Gross ER, Gross GJ. Ligand triggers of classical preconditioning and postconditioning. Cardiovasc. Res. 70(2), 212-221 (2006).
34. Penna C, Mancardi D, Rastaldo R, Losano G, Pagliaro P. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc. Res. 75(1), 168-177 (2007).
35. Tsutsumi YM, Yokoyama T, Horikawa Y, Roth DM, Patel HH. Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci. 81(15), 1223-1227 (2007).
36. Buckberg GD. Myocardial protection: an overview. Semin Thorac. Cardiovasc. Surg. 5, 98-106 (1993).
37. Okamoto F, Allen BS, Buckberg GD et al. Studies of controlled reperfusion after ischemia: XIV. Reperfusion conditions: importance of ensuing gentle versus sudden reperfusion during relief of coronary occlusion. J. Thorac. Car&ovasc. Surg. 92, 613 (1986).
38. Acar Partington MT, Buckberg GD. Studies of controlled reperfusion: reperfusion conditions: controlled reperfusion through an internal mammary artery graft - a new technique emphasizing fixed pressure versus fixed flow. J. Thorac. Cardiovasc. Surg. 100, 724-736 (1990).
39. Na HS, Kim YI, Noon YW, Han HC, Nahm SH, Hong SK. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am. Heart J. 132, 78-83 (1996).
40. Zhao ZQ, Corvera JS, Hatkos ME et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 285(2), 579-588 (2003).
41. Kin H, Zhao ZQ, Sun HY et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc. Res. 62(1), 74-85 (2004).
42. + exchange. Circ. Res. 66, 1156-1159 (1990).
43. Manning AS, Coltart DJ, Hearse DJ. Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol on postconditioning and reperfusion arrhythmia. Circ. Res. 55(4), 545-548 (1984).
44. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrhythmias and oxygen-derived fiee radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ. Res. 58, 331-340 (1986).
45. Grech ED, Dodd NJ, Bellamy CM, Perry RA, Morrison WI, Ramsdale DR. Free-radical generation during angioplasty reperfusion for acute myocardial infarction. Lancet 341, 990-991 (1993).
46. Pallandi RT, Perry MA, Campbell TJ. Proarrhythmic effects of an oxygen-derived free radical generating system on action potentials recorded from guinea pig ventricular myocardium: a possible cause of reperfusioninduced arrhythmias. Circ. Res. 61, 50-54 (1987).
47. Cerbai E, Ambrosio G, Porciatti F, Chiariello M, Giotti A, Mugelli A. Cellular electrophysiological basis for oxygen radical-induced arrhythmias. A patchclamp study in guinea pig ventricular myocytes. Circulation 84, 1773-1782 (1991).
48. Na HS, Kim YI, Yoon YW, Han HC, Nahm SH, Hong SK. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am. Heart J. 132, 78-83 (1996)
49. Galagudza M, Kurapeev D, Mirtasian S, Valen G, Vaage J. Ischemic postconditioning: brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm. Eur. J. Cardiothorac. Surg. 25(6), 1006-1010 (2004).
50. Petrishchev NN, Vlasov TD, Galagudza MM, Kurapeev DI, Minasian SM. Myocardial ischemic postconditioning: a brief ischemia causes conversion of resistent reperfusion-induced ventricular fibrillation into the normal rhythm. Ross. Fiziol. Zh. Im. I. M. Sechenova 90(9), 1138-1144 (2004).
51. Shliakhto EV, Galagudza MM, Syrenskii AV, Tsyrlin VA. Ischemic postconditioning of the myocardium: a new method of heart protection against reperfusion damage. Ter Arkh. 77(5), 77-80 (2005).
52. Vinten Johansen J,, Zhao ZQ, Jiang R, Zatta AJ, Dobson GP. Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury. J. Appl. Physiol. 103(4), 1441-1448 (2007).
53. Kin H, Zhao ZQ, Sun HY et at Postconditioning attenuates myocardial ischemia - reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc. Res. 62(1), 74-85 (2004).
54. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J. Am. Coll. Cardiol. 44(5), 1103-1110 (2004).
55. Serviddio G, Di Venosa N, Federici A et al. Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxide production and glutathione depletion. FASEB J. 19(3), 354-361 (2005).
56. 2+ overload. Am. J. Physiol. Heart Circ. Physiol. 288(4), 1900-1908 (2005).
57. Wang HC, Zhang HF, Guo WY et al. Hypoyic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: role of peroxynitrite formation. Apoptosis 11(8), 1453-1460 (2006).
58. Halkos ME, Kerendi F, Corvera JS et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann. Thorac. Surg. 78(3), 961-969 (2004).
59. Ye TM, Gao Q, Li YF, Wang J, Xia Q. Cardioprotective effect of ischemic postconditioning and preconditioning against prolonged ischemia and reperfusion induced injury in isolated rat heart. Zhejiang Da Xue Xue Bao Yi Xue Ban 36(1), 35-40 (2007).
60. Sato H, Bolli R, Rokosh GD, Bi Q, Dai S, Shirk G, Tang XL. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats. Am. J. Physiol. Heart. Circ. Physiol. 293(4), H2557-H2564 (2007).
61. Kerendi F, Kin H, Halkos ME et al. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res. Cardiol. 100(5), 404-412 (2005).
62. Andreka G, Vertesaljai M, Szantho G et al. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs. Heart 93(6), 749-752 (2007).
63. Li CM, Zhang XH, Ma XJ, Luo M. Limb ischemic postconditioning protects myocardium from ischemia-reperfusion injury. Scand. Cardiovasc. J. 40(5), 312-317 (2006).
64. Staat P, Rioufol G, Piot C et al. Postconditioning the human heart. Circulation 112(14), 2143-2148 (2005).
65. Laskey WK. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter. Cardiovasc. Interv. 65, 361-367 (2005).
66. Darling CE, Solari PB, Smith CS, Furman MI, Przyklenk K. 'Postconditioning' the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Res. Cardiol. 102(3), 274-278 (2007).
67. Iliodromitis EK, Zoga A, Vrettou A et al. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 188, 356-362 (2006).
68. Lu W, Li B, Lin G, Huang R. Postconditioning in cardiac surgery for tetralogy of Fallot. J. Thorac. Cardiovasc. Surg. 133(5), 1373-1374 (2007).
69. Heusch G. Postconditioning: old wine in a new bottle? J. Am. Coll. Cardiol. 44(5), 1111-1112 (2004).